Style | Citing Format |
---|---|
MLA | Javadpour P, et al.. "Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells." Physiology and Pharmacology (Iran), vol. 25, no. 1, 2021, pp. 76-82. |
APA | Javadpour P, Askari S, Azizi F, Ghasemi R (2021). Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells. Physiology and Pharmacology (Iran), 25(1), 76-82. |
Chicago | Javadpour P, Askari S, Azizi F, Ghasemi R. "Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells." Physiology and Pharmacology (Iran) 25, no. 1 (2021): 76-82. |
Harvard | Javadpour P et al. (2021) 'Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells', Physiology and Pharmacology (Iran), 25(1), pp. 76-82. |
Vancouver | Javadpour P, Askari S, Azizi F, Ghasemi R. Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells. Physiology and Pharmacology (Iran). 2021;25(1):76-82. |
BibTex | @article{ author = {Javadpour P and Askari S and Azizi F and Ghasemi R}, title = {Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells}, journal = {Physiology and Pharmacology (Iran)}, volume = {25}, number = {1}, pages = {76-82}, year = {2021} } |
RIS | TY - JOUR AU - Javadpour P AU - Askari S AU - Azizi F AU - Ghasemi R TI - Time Course Study of Erk1/2 Activity and Cell Viability in Lipopolysaccharide Challenged Pc12 Cells JO - Physiology and Pharmacology (Iran) VL - 25 IS - 1 SP - 76 EP - 82 PY - 2021 ER - |